Related Experiment Video
Updated: Jun 9, 2026

Production and Testing of Antimicrobial Peptides and Their Mimics
Published on: April 10, 2026
In silico-screened short amidated peptides engineered for dual bactericidal action and antibiotic delivery through
Vadant Soni1, Navin Kumar1, Hemant K Gautam2
1Dr. B.R. Ambedkar Center for Biomedical Research, University of Delhi, New Delhi 110007, India; Department of Biomedical Science, Acharya Narendra Dev College, University of Delhi, Kalkaji, New Delhi 110019, India.
Engineered antimicrobial peptides (AMPs) are developed as ultra-short, dual-function antibacterials and drug carriers. These peptides show potent activity against multidrug-resistant pathogens and biofilms, offering a new nanoplatform for infection treatment.
Area of Science:
- Biochemistry
- Materials Science
- Computational Biology
Background:
- Engineered antimicrobial peptides (AMPs) are promising against multidrug-resistant (MDR) pathogens.
- Existing AMP candidates often lack systematic design, stability, and translational formats.
- Addressing these limitations is crucial for developing effective peptide-based therapies.
Purpose of the Study:
- To develop ultra-short cationic hexapeptides as dual-function antibacterials and drug carriers.
- To establish an integrated in silico to in vitro pipeline for peptide design and optimization.
- To create a modular design framework for peptide-based interventions against MDR infections.
Main Methods:
- Machine learning-guided screening of AMP databases and sequence space to identify lead peptides.
- Rational design of hexapeptides (V01, V02, V03) with C-terminal amidation to enhance stability and membrane interaction.
- In vitro testing against ESKAPE pathogens and biofilms, and development of a nanoplatform for drug delivery.
Main Results:
- Identified three lead hexapeptides (V01, V02, V03) with potent activity against ESKAPE pathogens, including MRSA.
- Demonstrated significant inhibition and disruption of bacterial biofilms by the lead peptides.
- Developed a novel nanoplatform using lead peptide V03 to encapsulate ornidazole, combining intrinsic antimicrobial activity with targeted drug delivery.
Conclusions:
- Data-driven, chemically stabilized short AMPs can be tuned for both direct bactericidal function and cargo delivery.
- The developed nanoplatform offers enhanced local antimicrobial efficacy and overcomes limitations of free-drug administration.
- This study outlines a modular design framework for developing peptide-based interventions against MDR infections.
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...

